We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

213 hedge funds and large institutions have $10.9B invested in BeOne Medicines Ltd in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 63 increasing their positions, 79 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $7.2B → $10.9B (+$3.68B)

37% more call options, than puts

Call options by funds: $36.6M | Put options by funds: $26.7M

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

0.31% less ownership

Funds ownership: 3.97% → 3.66% (-0.31%)

4% less funds holding

Funds holding: 222 → 213 (-9)

14% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 44

20% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 79

Holders
213
Holders Change
-9
Holders Change %
-4.05%
% of All Funds
3.42%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.19%
New
38
Increased
63
Reduced
79
Closed
44
Calls
$36.6M
Puts
$26.7M
Net Calls
+$9.81M
Net Calls Change
+$515K

Top Buyers

1
Primecap Management
Primecap Management
California
+$57.4M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$36.5M
3
Capital International Investors
Capital International Investors
California
+$34.1M
4
FFM
Fairmount Funds Management
Pennsylvania
+$28.1M
5
Invesco
Invesco
Georgia
+$20.3M

Top Sellers

1
BlackRock
BlackRock
New York
-$382M
2
State Street
State Street
Massachusetts
-$106M
3
Goldman Sachs
Goldman Sachs
New York
-$39.7M
4
Legal & General Group
Legal & General Group
United Kingdom
-$36.8M
5
UBS AM
UBS AM
Illinois
-$32.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$2.57B – – –
Capital International Investors
2
Capital International Investors
California
$1.49B +$34.1M +186,203 +3%
HA
3
HHLR Advisors
Cayman Islands
$1.2B – – –
Primecap Management
4
Primecap Management
California
$1.11B +$57.4M +313,175 +7%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$750M +$36.5M +198,778 +6%
Temasek Holdings
6
Temasek Holdings
Singapore
$684M – – –
Invesco
7
Invesco
Georgia
$642M +$20.3M +110,524 +4%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$586M +$10.5M +57,335 +2%
CII
9
Capital International Inc
California
$241M -$5.55M -30,290 -3%
BlackRock
10
BlackRock
New York
$155M -$382M -2,083,577 -75%
AG
11
Artal Group
Luxembourg
$132M -$9.17M -50,000 -8%
BC
12
Boxer Capital
California
$110M – – –
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$101M +$2.51M +13,676 +3%
PIF
14
Public Investment Fund
Saudi Arabia
$69.9M – – –
Bank of America
15
Bank of America
North Carolina
$69.1M +$2.29M +12,501 +4%
CGPCS
16
Capital Group Private Client Services
California
$56.7M -$947K -5,165 -2%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$54.2M -$1.27M -6,918 -3%
FFM
18
Fairmount Funds Management
Pennsylvania
$52.7M +$28.1M +153,043 +177%
BA
19
Bridgewater Associates
Connecticut
$41.4M -$27.2M -148,132 -44%
Morgan Stanley
20
Morgan Stanley
New York
$40M -$1.73M -9,413 -5%
State Street
21
State Street
Massachusetts
$36.6M -$106M -575,410 -78%
ZAM
22
Zeal Asset Management
Hong Kong
$31.1M – – –
CIS
23
Capital International Sarl
California
$28.2M +$849K +4,628 +4%
MGIM
24
M&G Investment Management
United Kingdom
$27.4M +$4.35M +23,721 +24%
PAMS
25
Pictet Asset Management (Switzerland)
Switzerland
$27.3M -$27.9M -152,208 -55%
1
2 3 4 5

ONC Hedge Fund Activity: Q4 2022 in Review

213 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2022, worth a combined $10.9B — up 51% from $7.2B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of ONC and 38 opened new positions — a net loss of 6 holders — while 79 trimmed existing stakes and 63 added.

The largest buyer was Primecap Management, adding an estimated $57.4M. The largest seller was BlackRock, cutting an estimated $382M.

  • 213 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $10.9B of BeOne Medicines Ltd stock for Q4 2022, up 51% quarter-over-quarter.
  • 38 funds opened new BeOne Medicines Ltd positions in Q4 2022 and 44 closed out, a net change of -6 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2022 was Primecap Management, an estimated $57.4M added.
  • The largest BeOne Medicines Ltd seller in Q4 2022 was BlackRock, an estimated $382M sold.

Based on aggregated 13F filings for Q4 2022.